Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Pivotal, Double-Blinded Within-subject Comparison of the Marcus Autism Center Investigational Device and Current Best Practice Clinical Diagnosis For Autism Spectrum Disorder in Pediatric Subjects 16-30 Months of Age

NCT03469986 is registered in ClinicalTrials.gov with EarliTec Diagnostics, Inc as lead sponsor.

NCT NCT03469986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03469986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Pivotal, Double-Blinded Within-subject Comparison of the Marcus Autism Center Investigational Device and Current Best Practice Clinical Diagnosis For Autism Spectrum Disorder in Pediatric Subjects 16-30 Months of Age
Lead sponsor
EarliTec Diagnostics, Inc
Phase
Observational
Overall status
Completed
Start date
April 7, 2018
Completion date
May 31, 2019
Enrollment
505 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder